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Abstract: Consumption of anthocyanins (ACNs), due to their antioxidant, anti-inflammatory and 
anti-apoptotic effects, has been proposed for the prevention and treatment of several different 
diseases and conditions. ACNs are recognized as one of the leading nutraceuticals for prolonging 
health benefits through the attenuation of oxidative stress, and inflammatory or age-related 
diseases. Increased consumption of ACNs has the potential to attenuate the damage ensuing from 
oxidative stress, inflammation, enhance cardiometabolic health, and delay symptoms in 
predisposed neuropathology. A myriad of evidence supports ACN consumption as complementary 
or standalone treatment strategies for non-communicable diseases (NCDs) including obesity, 
diabetes, cardiovascular disease (CVD), neurodegenerative diseases, as well as, more recently, for 
the modulation of gut bacteria and bone metabolism. While these findings indicate the beneficial 
effects of ACN consumption, their food sources differ vastly in ACN composition and thus 
potentially in their physiological effects. Consumption of foods high in ACNs can be recommended 
for their potential beneficial health effects due to their relatively easy and accessible addition to the 
everyday diet. 
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1. Introduction 
Similar to most plant bioactive compounds, anthocyanins (ACNs) are found in a ‘natural’ 
abundance within the human diet and are proposed to induce positive effects on overall health [1,2]. 
Anthocyanins are water-soluble plant pigments that are prominent in the flesh, skin and roots of 
many coloured fruits and vegetables such as berries, plums and cherries [2]. Over the last decade, 
there has been an emphasis on researching the diet–disease relationship, together with the promotion 
of a nutrient-dense diet and exploration of ‘value-added’ food for their use as potential therapeutic 
strategies to minimize adverse health risks [2,3]. Relatively recent evidence has also emerged from 
clinical trials suggesting that the consumption of specific foods, beverages and nutraceuticals, such 
as those rich in ACNs, is associated with reduced risk for chronic, non-communicable diseases 
(NCDs) [2,4]. Non-communicable diseases comprise a ‘cluster’ of diseases including cancers, obesity, 
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diabetes and cardiovascular disease (CVD), accounting for the majority of deaths in developed 
countries [2,4]. 
The ACN composition can vary between different sources and varieties of foods [5], depending 
on whether they are fresh, frozen or dried [6], with seasonability and environmental stress [7], as well 
as with food storage and preparation techniques (i.e., peeled, unpeeled) indicating that their presence 
might be concentrated in specific areas of fruits and vegetables such as the skin or flesh [5,8]. In 2002, 
the consumption of ACNs was estimated to be 12.5 mg/day/person in the United States, although it 
is anticipated that this number has risen due to the increased popularity of the so-called ‘superfood’ 
market for health and wellbeing [9–11]. Although widely distrubted in a variety of different coloured 
fruits and vegetables, common sources of ACNs include blueberries, blackberries, raspberries, and 
aronia fruits, while less common sources include black legumes and the purple prickly pear [12–15]. 
These common sources (Table 1) have concentrations ranging from 127 to 15,000 mg/kg, and the 
application of ACNs as a food source of treatment is frequently limited by their low bioavailability 
[12,14,16]. 
ACNs have also been proposed to attenuate reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) in human, animal and in vitro studies [17–20]. The ROS are typically produced in the 
cytosol, mitochondria, endoplasmic reticulum and lysosomes, whereas RNS are produced primarily 
as a result of amino acid metabolism [21]. Both ROS and RNS are produced under normal 
circumstances by all aerobic cells and play an important part in cellular aging, as well as in pathologic 
inflammation and the progression of age-related NCDs [21,22]. A synergistic relationship between 
oxidative stress and NCDs has emerged as an important area of focus used for the identification of 
novel diagnostic biomarkers, as well as potential drug and therapeutic intervention strategies for the 
management and prevention of metabolic syndrome, diabetes, CVD and some neurodegenerative 
disorders [23]. 
The consumption of different ACNs in the form of foods, beverages and nutraceuticals has been 
investigated for the antioxidant effects they exhibit, as well as for their role in mediating 
inflammation, affecting body composition, cardiometabolic biomarkers, neurological pathology, gut 
microbiota, and a general delayed onset of disease [17,24–26]. However, there is an emerging need 
for an integrated focus on ACN consumption and their associated effects on commonly occurring 
NCDs across the lifespan, as well as recent evidence that they may enhance overall quality of life [4]. 
Therefore, this review will focus on recent human, animal and in vitro studies, assessing the 
consumption of ACNs and ACN-rich foods as potential therapeutics for mitigating oxidative 
damage, targeting inflammation and other pathways associated with the pathogenesis of chronic 
inflammatory or age-related NCDs. 
Table 1. Range of total anthocyanin content in commonly consumed fruits 1. 
Fruit  Total Content (mg/kg) 
Bilberry  4600 
Blackberry 820–1800 
Blueberry 825–5300 
Cherry 3500–4500 
Chokeberry 5060–10000 
Elderberry 2000–15600 
Raspberry 100–600 
Strawberry 127–360 
1 Table adapted from Horbowicz et al. (2008) [12]. 
2. Methods 
Herein, we discuss the involvement of ACNs and the supportive roles they carry out in relation 
to oxidative damage, body composition, metabolic syndrome, as well as cardiovascular and 
neurological diseases. The scope of this review also extends to these factors contributing to a general 
delay in disease onset, as well as exploring more recent and emerging evidence. 
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A comprehensive database search was initially carried out in January 2020 and subsequently 
repeated in April 2020. Searches were conducted across CINAHL, PubMed, SCOPUS, and the 
Cochrane Library electronic databases. Searches were performed using a combination of the 
following terms and their derivations: ‘anthocyanin’, ‘oxidative stress’, ‘chronic inflammation’, ‘free 
radical’ and ‘disease’. Additionally, reference lists of relevant, previously published review articles 
were searched. Several reviews have focused on the effects of ACN consumption and the effects on 
overall health in a broad sense, therefore a comprehensive review focusing on these integrated 
pathways is needed. Thus, subtopics representing these specific integrated processes and diseases 
were selected based on their prevalence and significance to the research field. 
3. Discussion of Findings 
3.1. Oxidative Damage, ROS and RNS Production 
Oxidative damage is proposed to play an important and causative role in the initiation, 
development and progression of several NCDs [22,27]. The damage ensued from ROS/RNS 
interactions has been associated with inflammation, lipid oxidation and several neurodegenerative 
disorders [28,29]. It is proposed that this mainly occurs due to the oxidative modification of major 
cellular macromolecules such as carbohydrates (CHOs), lipids, proteins, and more specifically, DNA 
[22]. With the ability to potentially scavenge free radicals and reduce oxidative stress, ACNs from a 
diet high in fruits and vegetables have been linked to slowing oxidative damage progression [30–32]. 
Endogenously, sources of ROS and RNS can occur via the nicotinamide adenine dinucleotide 
phosphate (NADPH) pathway, and when NADPH oxidase is activated, a large amount of oxygen 
(O2) and hydrogen peroxide (H2O2) are generated, causing extensive cellular proliferation [21]. If not 
suppressed, this can further lead to detrimental cellular changes and the initiation of many 
inflammatory and age-related diseases [21,33]. Dietary antioxidants are proposed to protect 
biological systems from free radical toxicity via different pathways, and as potent antioxidants, ACNs 
possess the ability to act as reducing agents in the electron-transfer reaction pathway, donating 
electrons to the free radicals with unpaired electrons [2,34]. It is essential to consider that the 
proposed antioxidant capabilities of ACNs may also be attributable to the non-ACN properties 
commonly found in most ACN-rich food sources such as Vitamin C [30]. However, it has been 
postulated that the number of hydroxyl groups present on the glycosylated B-ring structure (Figure 
1) of ACNs is associated with their scavenging ability, and may directly influence their antioxidant 
capacity [2]. A study by Jian-Yun et al. (2015) compared the total antioxidative capability (T-AOC) of 
two ACN sources, the black bean peel extract and pomegranate peel extract, on oxidative stress-
induced hyperglacemia in mice [35]. The black bean peel extract had slightly higher antioxidative 
capability (13 U/mL T-AOC) compared to that of the pomegranate peel extract (10 U/mL T-AOC) 
[35]. This may also suggest that the color intensity of ACN sources might aid in identifying higher 
antioxidant properties [36]. In a 2018 study by Ali et al. (2018), mice who received an ACN 
supplement derived from Korean black beans (12 mg/kg) for thirty days overcame ROS activation 
and had significantly reduced markers for oxidative stress and lipid peroxidation when compared 
with a saline vehicle control group [18]. This indicates a valuable consideration for the use of ACNs, 
specifically those with intense pigmentation, for overcoming damage ensued by oxidative stress. 
While most food sources contain varying levels of ACNs, it should also be considered how the food 
source may affect the scavenging abilities, and if the darker or more intense the pigment is—the 
higher the antioxidant capacity it possesses [36,37]. 
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Figure 1. Basic chemical structure of anthocyanins . 
3.2. Body Composition 
It is well accepted that body composition is an indicator of systemic nutritional and general 
health status, and can also provide valuable information for the diagnosis and treatment of several 
diseases [38]. According to the World Health Organisation (WHO), more than 1.9 billion adults were 
classified as overweight in 2016, with more than 650 million of these adults considered obese [39] and 
it is expected that this number is only going to increase. This highlights the growing need for novel 
interventions for the treatment of NCDs that are both manageable and maintainable [34,40,41]. Body 
composition is an important factor for the diagnosis of obesity along with other diseases, and 
measurements of body mass index (BMI), visceral fat percentage, and waist circumference in 
combination with inflammatory biomarkers such as adipokine/adipocytokine levels, are useful 
markers indicating the extent of the physiological burden [34]. There is growing evidence that 
increased visceral fat, adipokines and a state of obesity contribute to permanently increased oxidative 
stress or damage [42]. This, in combination with the under-production of antioxidant defensive 
mechanisms, can lead to obesity-related complications, co-morbidities and increased risk factors for 
NCDs [28,42]. Therefore, beneficial changes to body composition may improve health and overall 
quality of life, and increasing evidence supports dietary flavonoids as beneficial for weight 
maintenance and biomarkers relating to body composition [43,44]. A study of 2734 female 
participants found that a higher intake of foods naturally rich in ACNs and flavone subclasses was 
inversely associated with significantly lower fat mass and abdominal fat accumulation [43]. 
Additionally, Takahashi et al. (2015) examined the consumption of chokeberries in rats, in which 
visceral fat accumulation was suppressed, potentially via inhibiting pancreatic lipase activity [45]. In 
an obese mouse model, freeze-dried blueberry and strawberry powders were assessed in relation to 
weight gain and body fat accumulation as a combination of a high- or low-fat diet, or as standalone 
supplements [46]. The standalone supplements proved to be more effective at inhibiting weight gain 
and the accumulation of body fat, as opposed to consuming them with or as part of a meal [46]. These 
findings are useful in determining the pharmacokinetics of particular ACN derivatives, and further 
clinical studies are needed to identify any additional potential benefits. Overall, the management and 
maintenance of body composition through ACN consumption is an attribute that can have beneficial 
‘flow-on’ effects for the prevention and mitigation of chronic diseases. 
3.3. Chronic Inflammation and Metabolic Syndrome 
Chronic inflammation has an extensive role in the pathogenesis of obesity and other associated 
metabolic diseases including insulin resistance, type 2 diabetes mellitus (T2DM) and CVD [34,41]. 
The potential to target inflammation is thus an appealing strategy to combat inflammatory-related 
diseases [32,34]. Ameliorating this burden with food-derived products, or ‘bioactives’, is a relatively 
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novel alternative to a traditional pharmaceutical approach; however, the subsequent alteration of 
metabolic markers is a common goal that, with limited side effects, is an efficient and cost-effective 
strategy worthy of consideration [3,32]. Among other pathways, obesity influences the activation of 
the innate immune system in adipose tissue that promotes pro-inflammatory pathways and induces 
ROS/RNS production, triggering a systemic acute immune response [42]. It is believed that impaired 
ability of adipocytes storing excess energy as triglycerides contributes to the accumulation of lipids 
and their metabolites in other tissues that are not necessarily adapted to lipid storage [42]. Inevitably, 
increased adiposity leads to oxidative stress, inducing monocyte infiltration into adipose tissue, and 
this innate immune response increases the risk for atherosclerotic plaque development, and 
ultimately, CVD [42,47]. A study by Kim et al. (2016) showed that blackcurrants (prepared from a 
dried powder, 6.3% w/w) inhibit macrophage infiltration in adipose tissue of obese mice, which is a 
vast contributor to the development of metabolic disorders via cytokine secretion by macrophages in 
adipose tissue—these cytokines play a role in promoting insulin resistance [48]. Insulin resistance 
occurs early in the progression of metabolic disorders and plays a pivotal role in the pathogenesis of 
T2DM. Human studies have suggested that ACNs could improve glucose tolerance, insulin 
sensitivity and reduce inflammatory markers such as Interleukin-6 (IL-6) through several cellular and 
molecular mechanisms [34,42]. Furthermore, the findings of a study by Vugic et al. (2020) in lean, 
overweight and obese individuals have also indicated that 320 mg/day of total ACNs decreased levels 
of IL-6 in the obese treatment group [36]. However, there is a lack of consensus regarding the effects 
of ACN consumption on insulin resistance. Homeostatic Model Assessment of Insulin Resistance 
(HOMA-IR) was significantly altered after six weeks of supplementation with tart cherry juice in 
diabetic women—suggesting that weight reduction and increased insulin sensitivity may be 
attainable through supplementation with ACN-rich juices [49]. In contrast, a 2019 study in 28 healthy 
participants supplementing with tart montmorency cherry for four weeks did not alter HOMA-IR or 
IL-6 [50]. Despite non-significant results of HOMA-IR in healthy populations, HOMA-IR was 
significantly reduced in diabetic, pre-diabetic and obese and overweight populations [51]. Purple 
potato extracts containing acylated ACNs have shown reductions in postprandial blood glucose and 
insulin peaks in an acute, randomized cross-over trial, indicating that this may alleviate postprandial 
glycemia and insulinemia [52]. In addition to the proposed metabolic benefits of ACNs, their anti-
inflammatory properties have also shown beneficial results in pain reduction and in inflammation in 
human clinical trials for inflammatory arthritis, which is often associated with obesity in later life, in 
addition to the increased risk of CVD [53]. 
3.4. Cardiovascular Disease 
The consumption of foods high in ACN content may contribute to positive cardiovascular effects 
[54]. Several systematic reviews and meta-analyses have investigated the effects of ACNs on 
cardiometabolic health, including factors such as lipid profile and hypertension [27,51,54,55]. 
Throughout CVD development, oxidative stress causes vascular inflammation, upregulating lipid 
molecules and thereby unfavourably altering levels of high-density lipoprotein cholesterol (HDL-C) 
and low-density lipoprotein cholesterol (LDL-C) [51,55]. This, in turn, results in the upregulation of 
cell adhesion molecules and increases the risk for vascular adversity [51]. As potential 
cardioprotective agents, ACNs have also been shown to attenuate oxidized LDL-C (oxLDL)-
mediated foam cell formation—one of the main drivers of atherogenesis—through inflammatory 
pathways, and more recently involving the regulation of CD36 gene expression (responsible for the 
encoding of glycoprotein IV) [56]. For example, ACN-rich hibiscus extract has prevented lipid 
accumulation, decrease CD36 expression and inhibit the macrophage uptake of oxLDL in vitro [56]. 
Additionally, results obtained from a double-blind, randomized, placebo-controlled trial showed that 
the consumption of a berry-derived ACN supplement (160 mg twice daily) for 12 weeks significantly 
increased serum HDL-C and decreased LDL-C when compared with placebo [57]. A study by Asgary 
et al. (2014) evaluated the cardiometabolic effects of pomegranate juice (150 mL/day) for two weeks 
in hypertensive patients aged between 30 and 37 years [58]. Results from this trial indicated that 
pomegranate juice significantly reduced diastolic and systolic blood pressure, but not flow-mediated 
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dilation [58]. As CVD, and associated risk markers, have both modifiable lifestyle and inherited 
factors, populations considered to be at increased risk are overweight and obese populations, 
smokers, those with a family history, and postmenopausal women, specifically. Supplementing with 
elderberry extract (500 mg/day) for 12 weeks was shown to be ineffective in reducing risk of CVD in 
healthy, postmenopausal women [59]. This result was intriguing, as postmenopausal status is 
commonly associated with an increase in oxidative stress [19]. Given the study length, and that 
estrogen has shown a potential cardioprotective benefit in females, it may be worth exploring the 
concept of ACN supplementation in the presence and absence of particular sex hormones, as this 
may inhibit the efficacy of its scavenging effects in relation to cardiovascular health [19,59]. However, 
bilberries were shown to be effective in improving bone health in menopause populations [19] and a 
human clinical trial conducted in 2016 assessing bilberry supplementation reported significantly 
reduced CVD risk factors, by inducing favorable changes in the lipoprotein profiles in menopausal 
women [60]. This may be more of a reflection of the type of ACN food constituents, rather than the 
efficacy of ACNs in general. The overall findings indicate that ACN consumption may have beneficial 
effects on cardiometabolic biomarkers, and support their consideration as an alternative method of 
prevention and treatment of CVD and associated risk markers. Further long-term trials are needed 
to explore optimal ACN food sources, dosage and duration in a range of at-risk populations. 
3.5. Alzheimer’s, Parkinson’s and Other Neurological Diseases 
Approximately 20% of the bodies total oxygen supply is consumed by the brain, of which, a 
significant portion is converted to ROS [29]. As oxidative damage poses stress on DNA, proteins and 
lipids, the brain is vulnerable to neuronal degradation and can progress to neurological pathology 
such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) [23]. The pathogenesis of AD is 
considered to have a multifaceted origin and oxidative stress has been widely accepted in its etiology, 
as well as consideration of lifestyle factors including poor diet and sedentary behavior, both of which 
have been shown to accelerate Amyloid beta (Aβ) accumulation [29,61,62]. Similarly, RNS are also 
found to contribute to AD pathology through excitotoxicity of N-methyl-D-aspartate receptors, 
where they become permeable to calcium, potassium and sodium ions [61,63]. Abnormal intracellular 
ion levels induce mitochondrial damage and ROS production by increasing the mitochondrial ion 
burden and inducing mitochondrial dysfunction [24,63]. On the other hand, PD is characterized by a 
loss of dopaminergic neurons [64], and while the exact etiology of PD remains unclear, the 
understanding of oxidative stress in relation to dopamine metabolism and neuroinflammation 
remain important informants in its progression [23,64]. The ACNs were also investigated for their 
ability to diminish glutamate-induced neurotoxicity, and their antioxidant activities are of great 
interest in AD and PD [23]. The in vitro study using the purple sweet potato showed a strong free 
radical scavenging effect and reduced A-induced-toxicity in an animal derived PC12 cell line [20]. 
Additionally, mulberry fruit isolates have also been reported to have some degree of neuroprotection 
against cerebral ischemia in a PC12 cell line, indicating the capacity to minimize ischemic cell death 
as a result of vascular narrowing or stroke [65]. This could potentially improve brain-trauma 
outcomes and overall quality of life in stroke patients. The neuroprotective benefits of blueberry juice 
has also shown promise in enhancing signalling pathways and preventing behavioural deficits in an 
AD mouse model, and a recent human trial conducted by Krikorian et al. (2020) highlighted that this 
may be a possible path to overcome genetic predisposition to AD [66,67]. However, there is only 
mixed, preliminary evidence supporting the use of blueberries and blueberry products on cognitive 
performance and mood [68]. There remains a need for future consideration of ACN derivatives as a 
novel therapeutic approach to managing the progression of life-changing neurological illnesses. 
3.6. Delayed Onset of Disease 
As ACNs and their metabolites have shown promise as potential therapeutic agents for 
neurodegenerative diseases such as AD and PD, further investigation of prolonged healthspan in 
individuals predisposed to, or with preexisting neuropathologies, is important [23]. Amyotrophic 
Lateral Sclerosis (ALS), or more socially termed ‘Lou Gehrig’s Disease’, is currently an incurable 
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degenerative disorder affecting the central nervous system (CNS) and eventually leads to 
diminishing skeletal muscle integrity [69]. Pre-symptomatic supplementation with ACN-enriched 
extract from strawberries significantly delayed disease onset in an ALS mouse model [70]. The study 
reported a delay in disease onset, in addition to a significant extension in survival rates in this animal 
model [70]. These findings provide support for future exploration in human trials, as well as potential 
preclinical models of other neurodegenerative diseases. Aging has been associated with an increase 
in DNA damage, and without effective response and repair pathways, proliferating stressors can lead 
to irreparable DNA damage [71]. The aging of the liver is a natural process that occurs at a stable but 
irreversible rate; therefore, a decline in liver function occurs concurrently with the aging process [72]. 
Age-related liver diseases are accompanied by high rates of morbidity and mortality, increasing 
disease risk such as chronic hepatitis and liver cirrhosis [72]. In recent years, the black chokeberry has 
been widely used due to its high ACN content and relatively strong antioxidant activity [33]. A study 
by Wei et al. (2017) observed the effects of black chokeberry supplementation (eight weeks) on DNA 
damage inhibition and liver function in mice [33]. Findings indicated that the treatment groups were 
more effective in slowing the age-related degeneration of the whole liver, highlighting that ACNs 
could be a promising and accessible potential source of anti-aging agents. 
3.7. Emerging Evidence 
There are several health-promoting benefits attributable to the inhibition of oxidative stress 
proposed by ACN consumption (Figure 2), including the modulation of gut microbiota [73]. Some 
dietary ACNs have been studied for their ability to act as prebiotics, beneficially modulating the gut 
microbiome [74]. The changes in gut microbiota have also been strongly associated with obesity, and 
recent studies have shown that non-absorbable flavonoids or polyphenol subclasses alter the gut 
microbial community, resulting in lower systemic inflammation and improved metabolic outcomes 
[26,74,75]. Interestingly, there is emerging evidence suggesting that the polyphenols and ACNs 
present in red wine pose beneficial effects to the gut microbiota not observed in other alcoholic 
beverages [26,76]. Together, these are novel leads in the potential of non-absorbed compounds in 
treating metabolic disorders. In addition to their cardioprotective and anti-inflammatory properties, 
the intake of berries may improve bone health, and often overlooked are the effects that ACNs could 
have on populations who are increasingly susceptible to CVD and other inflammatory diseases such 
as osteoporosis and arthritis. Relatively recently, it has been indicated that the endocrine system is 
involved in the modulation of oxidative stress through hormonal homeostasis [19]. Oxidative stress 
is evident in the pathogenesis of many endocrine diseases as well as bone degeneration [19,77]. 
Polyphenols, as a broader class, have been shown to protect bone health through the modulation of 
osteoblastogenesis, osteoclastogenesis and osteoimmunological action [78]. Importantly, this 
emerging research on bone health paves the way for the general use of ACNs as therapeutic 
interventions for individuals suffering from inflammatory, menopausal or age-related bone 
degeneration. 
Segments of DNA such as telomeres are highly sensitive to oxidative damage, and the diet may 
impact telomere attrition rates with respects to mediating oxidative stress and inflammation. 
Telomeres are nucleoprotein complexes capping the ends of chromosomes, serving to protect 
eukaryotes from DNA damage, preventing end-to-end fusion and limiting the capacity for extensive 
cellular replication [79,80]. Telomeres naturally shorten with every round of DNA replication, 
eventually leading to cellular senescence [80]. Increased telomere attrition rates are associated with 
reduced relative telomere length and genomic instability—increasing the risk of DNA damage, 
excessive production of ROS/RNS and linking to the progression and development of NCDs and 
reduced longevity [79,80]. Recently, it has been proposed that consumption of food rich in ACNs, 
through their antioxidant properties complementing the removal of excessive ROS/RNS, may relieve 
the extensive damage caused to DNA as a result of oxidative stress [81]. This may delay shortening 
of telomeres, decrease the risk of NCDs and promote longevity—an ultimate goal encouraging ‘food 
for thought’. 
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Figure 2. A proposed pathway facilitating the removal of ROS/RNS by internal antioxidant systems 
with ACN support. ROS/RNS production is a natural process occurring in most aerobic cells. 
Increased production is therefore related to injurious stimuli. Internal antioxidant systems are present 
to facilitate the removal of normal ROS/RNS production (pictured at point 1); however, inadequate 
removal or excessive production can result in cellular pathology such as lipid, protein and DNA 
damage (pictured at point 2). Anthocyanins can support this facilitated removal through their 
additional antioxidant properties, preventing further pathological progression. 
4. Summary of Findings 
An important element to recognize throughout this review is that there are several overlapping 
and ‘flow-on’ effects that influence individual physiological systems and human health as a whole. 
Oxidative stress is a key player in disease onset and progression, and ACNs consumption may 
mitigate this by counteracting the oxidative damage to biological molecules such as lipids and DNA. 
Although inflammation is regarded as a normal physiological response, when considered from a 
pathological perspective or as a chronic condition, it can pose extensive stress on the body. Both 
inflammation and oxidative stress have the potential to be offset with the anti-inflammatory and 
antioxidant properties of ACNs. The most common sources of ACNs explored in this review were 
predominantly from berries (blueberry, strawberry, mulberry, chokeberry, bilberry, and elderberry). 
Importantly, the consumption and availability of specific ACNs differ broadly among demographic 
populations, geographical location, as well as with climate and seasons. Therefore, daily 
consumption or recommended consumption to see expected results remains controversial. Generally, 
study designs that used a longer intervention period (greater than 12 weeks) observed positive effects 
on cardiometabolic factors, body composition and suggest ACNs may be effective in reducing 
HOMA-IR in obese adults. Delayed onset of disease in animal models is also one of the key takeaways 
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from this review, with which timely and appropriate ACN supplementation has the potential to 
increase healthspan and overall quality of life. 
Overall, the findings from this review indicate that ACNs exhibit antiatherogenic, antioxidant, 
anti-inflammatory and anti-apoptotic properties. However, their composition differs vastly in many 
food sources, and thus potentially in the physiological effects after consumption. 
5. Conclusions and Future Directions 
We reviewed the effects of ACNs beyond their antioxidant capacity in relation to overall human 
health, specifically regarding NCD progression and prevention. Sources of ACNs found naturally in 
the diet including, but not limited to strawberries, mulberries, blueberries, elderberry and 
pomegranate, may represent a suitable non-pharmaceutical approach to the regulation of oxidative 
stress, and inflammatory-related diseases. A vast majority of the literature included were from animal 
models or in vitro studies. While promising, the findings from these studies warrant further 
exploration in human populations. This review did not focus on the bioavailability of specific ACNs 
or ACN-rich food sources, and with a plethora of literature available it is recommended to consider 
this information when designing human trials, as there are factors affecting absorption that may 
render the molecules less effective. 
Overall, consumption of ACNs as standalone or combination therapy may prove to be a reliable 
and effective approach to the prevention and management of age or inflammatory-related diseases. 
Author Contributions: N.N., A.J.M. and H.S. conceived the topic; H.S. performed the review; H.S. drafted the 
paper; N.M.D, N.I.A, A.J.M and N.N. provided critical feedback. All authors contributed significantly to this 
submission. All authors have read and agreed to the published version of the manuscript. 
Acknowledgments: H.S. is supported by an Australian Government Research Training Program Scholarship 
and acknowledges the contribution of the Commonwealth. N.M.D is supported by a PhD Scholarship awarded 
by the Dementia Australia Research Foundation. 
Conflicts of Interest: N.N. and A.J.M. have received the funding from Chiron Organic Health, which is 
registered with the University of Canberra Research and Innovation Office (Reg: UC-R00141). The funders had 
no role in the design of the study; in collection, analyses, or interpretation of data; or in the decision to publish 
the results. N.I.A. is an owner of Chiron Organic Health. 
References 
1. Zafra-Stone, S.; Yasmin, T.; Bagchi, M.; Chatterjee, A.; Vinson, J.A.; Bagchi, D. Berry anthocyanins as novel 
antioxidants in human health and disease prevention. Mol. Nutr. Food Res. 2007, 51, 675–683, 
doi:10.1002/mnfr.200700002. 
2. Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and anthocyanins: Colored pigments as food, 
pharmaceutical ingredients, and the potential health benefits. Food Nutr. Res. 2017, 61, 1361779, 
doi:10.1080/16546628.2017.1361779. 
3. Li, D.; Wang, P.; Luo, Y.; Zhao, M.; Chen, F. Health benefits of anthocyanins and molecular mechanisms: 
Update from recent decade. Crit. Rev. Food Sci. Nutr. 2017, 57, 1729–1741, doi:10.1080/10408398.2015.1030064. 
4. D’Cunha, N.M.; Georgousopoulou, E.N.; Dadigamuwage, L.; Kellett, J.; Panagiotakos, D.B.; Thomas, J.; 
McKune, A.J.; Mellor, D.D.; Naumovski, N. Effect of long-term nutraceutical and dietary supplement use 
on cognition in the elderly: A 10-year systematic review of randomised controlled trials. Br. J. Nutr. 2018, 
119, 280–298, doi:10.1017/S0007114517003452. 
5. Kim, I.; Lee, J. Variations in Anthocyanin Profiles and Antioxidant Activity of 12 Genotypes of Mulberry 
(Morus spp.) Fruits and Their Changes during Processing. Antioxidants 2020, 9, 242. 
6. Sun, Y.; Zhang, Y.; Xu, W.; Zheng, X. Analysis of the Anthocyanin Degradation in Blue Honeysuckle Berry 
under Microwave Assisted Foam-Mat Drying. Foods 2020, 9, 397. 
7. Hinojosa-Gómez, J.; San Martín-Hernández, C.; Heredia, J.B.; León-Félix, J.; Osuna-Enciso, T.; Muy-Rangel, 
M.D. Anthocyanin Induction by Drought Stress in the Calyx of Roselle Cultivars. Molecules 2020, 25, 1555. 
8. Di Gioia, F.; Tzortzakis, N.; Rouphael, Y.; Kyriacou, M.C.; Sampaio, S.L.; C.F.R. Ferreira, I.; Petropoulos, 
S.A. Grown to Be Blue—Antioxidant Properties and Health Effects of Colored Vegetables. Part II: Leafy, 
Fruit, and Other Vegetables. Antioxidants 2020, 9, 97. 
Antioxidants 2020, 9, 366 10 of 13 
9. Wu, X.; Beecher, G.R.; Holden, J.M.; Haytowitz, D.B.; Gebhardt, S.E.; Prior, R.L. Concentrations of 
Anthocyanins in Common Foods in the United States and Estimation of Normal Consumption. J. Agricult. 
Food Chem. 2006, 54, 4069–4075, doi:10.1021/jf060300l. 
10. NHANES. National Health and Nutrition Examination Survey Data; NHANES: Hyattsville, MD, USA, 2001. 
11. Szutowska, J.; Rybicka, I.; Pawlak-Lemańska, K.; Gwiazdowska, D. Spontaneously fermented curly kale 
juice: Microbiological quality, nutritional composition, antioxidant, and antimicrobial properties. J. Food 
Sci. 2020, 85, 1248–1255, doi:10.1111/1750-3841.15080. 
12. Horbowicz, M.; Kosson, R.; Grzesiuk, A.; Debski, H. Anthocyanins of Fruits and Vegetables—Their 
Occurrence, Analysis and Role in Human Nutrition. Veg. Crops Res. Bull. 2008, 68, 5, doi:10.2478/v10032-
008-0001-8. 
13. Naumovski, N. Bioactive composition of plants and plant foods. In Plant Bioactive Compounds for Pancreatic 
Cancer Prevention and Treatment, Nova Publishers: New York, NY, USA, 2014; pp. 81–115. 
14. Vuong, Q.V. Utilisation of Bioactive Compounds from Agricultural and Food Production Waste; CRC Press: Boca 
Raton, FL, USA, 2017. 
15. Kalt, W.; Cassidy, A.; Howard, L.R.; Krikorian, R.; Stull, A.J.; Tremblay, F.; Zamora-Ros, R. Recent Research 
on the Health Benefits of Blueberries and Their Anthocyanins. Adv. Nutr. 2019, 11, 224–236, 
doi:10.1093/advances/nmz065. 
16. Sharif, N.; Khoshnoudi-Nia, S.; Jafari, S.M. Nano/microencapsulation of anthocyanins; A systematic review 
and meta-analysis. Food Res. Int. 2020, 132, 109077, doi:10.1016/j.foodres.2020.109077. 
17. He, J.; Giusti, M.M. Anthocyanins: Natural colorants with health-promoting properties. Ann.Rev. Food Sci. 
Technol. 2010, 1, 163–187. 
18. Ali, T.; Kim, T.; Rehman, S.U.; Khan, M.S.; Amin, F.U.; Khan, M.; Ikram, M.; Kim, M.O. Natural Dietary 
Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, 
Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease. Mol. Neurobiol. 
2018, 55, 6076–6093, doi:10.1007/s12035-017-0798-6. 
19. Shimizu, S.; Matsushita, H.; Morii, Y.; Ohyama, Y.; Morita, N.; Tachibana, R.; Watanabe, K.; Wakatsuki, A. 
Effect of anthocyanin-rich bilberry extract on bone metabolism in ovariectomized rats. Biomed. Rep. 2018, 8, 
198–204, doi:10.3892/br.2017.1029. 
20. Ye, J.; Meng, X.; Yan, C.; Wang, C. Effect of purple sweet potato anthocyanins on β-amyloid-mediated PC-
12 cells death by inhibition of oxidative stress. Neurochem. Res. 2010, 35, 357–365. 
21. Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Role of ROS and RNS Sources in Physiological and 
Pathological Conditions. Oxid. Med. Cell. Longev. 2016, 44, doi:10.1155/2016/1245049. 
22. Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.; 
Bonaduce, D.; et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 2018, 13, 757–772, 
doi:10.2147/CIA.S158513. 
23. Ullah, R.; Kahn, M.; Shah, S.A.; Saeed, K.; Kim, M.O. Natural Antioxidant Anthocyanins—A Hidden 
Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration. Nutrients 2019, 11, 
1195, doi:10.3390/nu11061195. 
24. Sergi, D.; Naumovski, N.; Heilbronn, L.K.; Abeywardena, M.; O’Callaghan, N.; Lionetti, L.; Luscombe-
Marsh, N. Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular 
Mechanisms to the Impact of Diet. Front. Physiol. 2019, 10, 532, doi:10.3389/fphys.2019.00532. 
25. Munialo, C.D.; Naumovski, N.; Sergi, D.; Stewart, D.; Mellor, D.D. Critical evaluation of the extrapolation 
of data relative to antioxidant function from the laboratory and their implications on food production and 
human health: a review. Int. J. Food Sci. Technol. 2019, 54, 1448–1459, doi:10.1111/ijfs.14135. 
26. Nash, V.; Ranadheera, C.S.; Georgousopoulou, E.N.; Mellor, D.D.; Panagiotakos, D.B.; McKune, A.J.; Kellett, 
J.; Naumovski, N. The effects of grape and red wine polyphenols on gut microbiota—A systematic review. 
Food Res. Int. 2018, 113, 277–287, doi:10.1016/j.foodres.2018.07.019. 
27. Fallah, A.A.; Sarmast, E.; Jafari, T. Effect of dietary anthocyanins on biomarkers of oxidative stress and 
antioxidative capacity: A systematic review and meta-analysis of randomized controlled trials. J. Funct. 
Foods 2020, 68, 103912, doi:10.1016/j.jff.2020.103912. 
28. Marseglia, L.; Manti, S.; D’Angelo, G.; Nicotera, A.; Parisi, E.; Di Rosa, G.; Gitto, E.; Arrigo, T. Oxidative 
stress in obesity: A critical component in human diseases. Int. J. Mol. Sci. 2014, 16, 378–400, 
doi:10.3390/ijms16010378. 
Antioxidants 2020, 9, 366 11 of 13 
29. Chong, Z.Z.; Li, F.; Maiese, K. Oxidative stress in the brain: Novel cellular targets that govern survival 
during neurodegenerative disease. Prog. Neurobiol. 2005, 75, 207–246, doi:10.1016/j.pneurobio.2005.02.004. 
30. Einbond, L.S.; Reynertson, K.A.; Luo, X.-D.; Basile, M.J.; Kennelly, E.J. Anthocyanin antioxidants from 
edible fruits. Food Chem. 2004, 84, 23–28, doi:10.1016/S0308-8146(03)00162-6. 
31. Skemiene, K.; Pampuscenko, K.; Rekuviene, E.; Borutaite, V. Protective effects of anthocyanins against 
brain ischemic damage. J. Bioenerget. Biomembr. 2020, 52, 71–82, doi:10.1007/s10863-020-09825-9. 
32. Aboonabi, A.; Singh, I.; Rose’ Meyer, R. Cytoprotective effects of berry anthocyanins against induced 
oxidative stress and inflammation in primary human diabetic aortic endothelial cells. Chemico-Biol. Interact. 
2020, 317, 108940, doi:10.1016/j.cbi.2020.108940. 
33. Wei, J.; Zhang, G.; Zhang, X.; Xu, D.; Gao, J.; Fan, J. Anthocyanins Delay Ageing-Related Degenerative 
Changes in the Liver. Plant Foods Hum. Nutr. 2017, 72, 425–431, doi:10.1007/s11130-017-0644-z. 
34. Lee, Y.-M.; Yoon, Y.; Yoon, H.; Park, H.-M.; Song, S.; Yeum, K.-J. Dietary Anthocyanins against Obesity and 
Inflammation. Nutrients 2017, 9, 1089, doi:10.3390/nu9101089. 
35. Jian-Yun, W.; Chuang, Z.H.U.; Tian-Wei, Q.; Hao, G.U.O.; Dong-Dong, W.; Fan, Z.; Xiaoxing, Y.I.N. 
Extracts of black bean peel and pomegranate peel ameliorate oxidative stress-induced hyperglycemia in 
mice. Exp. Therap. Med. 2015, 9, 43–48, doi:10.3892/etm.2014.2040. 
36. Calderaro, A.; Barreca, D.; Bellocco, E.; Smeriglio, A.; Trombetta, D.; Laganà, G. Chapter Eight - Colored 
phytonutrients: Role and applications in the functional foods of anthocyanins. In Phytonutrients in Food; 
Nabavi, S.M., Suntar, I., Barreca, D., Khan, H., Eds.; Woodhead Publishing: Sawston, UK, 2020; pp. 177–
195. 
37. Wrolstad, R.E.; Durst, R.W.; Lee, J. Tracking color and pigment changes in anthocyanin products. Trends 
Food Sci.Technol. 2005, 16, 423–428, doi:10.1016/j.tifs.2005.03.019. 
38. Liang, X.; Chen, X.; Li, J.; Yan, M.; Yang, Y. Study on body composition and its correlation with obesity: A 
Cohort Study in 5121 Chinese Han participants. Medicine 2018, 97, e10722, 
doi:10.1097/md.0000000000010722. 
39. W.H.O. Obesity and Overweight. Available online: https://www.who.int/news-room/fact-
sheets/detail/obesity-and-overweight (accessed on 19 March 2020). 
40. Roth, J.; Qiang, X.; Marbán, S.L.; Redelt, H.; Lowell, B.C. The Obesity Pandemic: Where Have We Been and 
Where Are We Going? Obes. Res. 2004, 12, 88S–101S, doi:10.1038/oby.2004.273. 
41. Jayarathne, S.; Stull, A.J.; Park, O.-H.; Kim, J.H.; Thompson, L.; Moustaid-Moussa, N. Protective Effects of 
Anthocyanins in Obesity-Associated Inflammation and Changes in Gut Microbiome. Mol. Nutr. Food Res. 
2019, 63, 1900149, doi:10.1002/mnfr.201900149. 
42. Ellulu, M.S.; Patimah, I.; Khaza’ai, H.; Rahmat, A.; Abed, Y. Obesity and inflammation: The linking 
mechanism and the complications. Arch. Med. Sci. 2017, 13, 851–863, doi:10.5114/aoms.2016.58928. 
43. Jennings, A.; MacGregor, A.; Spector, T.; Cassidy, A. Higher dietary flavonoid intakes are associated with 
lower objectively measured body composition in women: Evidence from discordant monozygotic twins. 
Am. J. Clin. Nutr. 2017, 105, 626–634, doi:10.3945/ajcn.116.144394. 
44. Yarahmadi, M.; Askari, G.; Kargarfard, M.; Ghiasvand, R.; Hoseini, M.; Mohamadi, H.; Asadi, A. The effect 
of anthocyanin supplementation on body composition, exercise performance and muscle damage indices 
in athletes. Int. J. Prev. Med. 2014, 5, 1594–1600. 
45. Takahashi, A.; Shimizu, H.; Okazaki, Y.; Sakaguchi, H.; Taira, T.; Suzuki, T.; Chiji, H. Anthocyanin-rich 
Phytochemicals from Aronia Fruits Inhibit Visceral Fat Accumulation and Hyperglycemia in High-fat Diet-
induced Dietary Obese Rats. J. Oleo Sci. 2015, 64, 1243–1250, doi:10.5650/jos.ess15181. 
46. Prior, R.L.; Wu, X.; Gu, L.; Hager, T.J.; Hager, A.; Howard, L.R. Whole Berries versus Berry Anthocyanins: 
Interactions with Dietary Fat Levels in the C57BL/6J Mouse Model of Obesity. J. Agricult. Food Chem. 2008, 
56, 647–653, doi:10.1021/jf071993o. 
47. Abel, E.D.; O’Shea, K.M.; Ramasamy, R. Insulin resistance: Metabolic mechanisms and consequences in the 
heart. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2068–2076, doi:10.1161/ATVBAHA.111.241984. 
48. Kim, B.; Lee, S.G.; Park, Y.-K.; Ku, C.S.; Pham, T.X.; Wegner, C.J.; Yang, Y.; Koo, S.I.; Chun, O.K.; Lee, J.-Y. 
Blueberry, blackberry, and blackcurrant differentially affect plasma lipids and pro-inflammatory markers 
in diet-induced obesity mice. Nutr. Res. Pract. 2016, 10, 494–500. 
49. Ataie-Jafari, A.; Hosseini, S.; Karimi, F.; Pajouhi, M. Effects of sour cherry juice on blood glucose and some 
cardiovascular risk factors improvements in diabetic women: A pilot study. Nutr. Food Sci. 2008, 38, 355–
360, doi:10.1108/00346650810891414. 
Antioxidants 2020, 9, 366 12 of 13 
50. Lear, R.; O’Leary, M.; O’Brien Anderson, L.; Holt, C.C.; Stensvold, C.R.; van der Giezen, M.; Bowtell, J.L. 
Tart Cherry Concentrate Does Not Alter the Gut Microbiome, Glycaemic Control or Systemic Inflammation 
in a Middle-Aged Population. Nutrients 2019, 11, 1063, doi: 10.3390/nu11051063. 
51. Yang, L.; Ling, W.; Du, Z.; Chen, Y.; Li, D.; Deng, S.; Liu, Z.; Yang, L. Effects of Anthocyanins on 
Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv. 
Nutr. 2017, 8, 684–693, doi:10.3945/an.116.014852. 
52. Jokioja, J.; Linderborg, K.M.; Kortesniemi, M.; Nuora, A.; Heinonen, J.; Sainio, T.; Viitanen, M.; Kallio, H.; 
Yang, B. Anthocyanin-rich extract from purple potatoes decreases postprandial glycemic response and 
affects inflammation markers in healthy men. Food Chem. 2020, 310, 125797, 
doi:10.1016/j.foodchem.2019.125797. 
53. Basu, A.; Schell, J.; Scofield, R.H. Dietary fruits and arthritis. Food Funct. 2018, 9, 70–77, 
doi:10.1039/c7fo01435j. 
54. Daneshzad, E.; Shab-Bidar, S.; Mohammadpour, Z.; Djafarian, K. Effect of anthocyanin supplementation 
on cardio-metabolic biomarkers: A systematic review and meta-analysis of randomized controlled trials. 
Clin. Nutr. 2019, 38, 1153–1165, doi:10.1016/j.clnu.2018.06.979. 
55. Zhang, H.; Xu, Z.; Zhao, H.; Wang, X.; Pang, J.; Li, Q.; Yang, Y.; Ling, W. Anthocyanin supplementation 
improves anti-oxidative and anti-inflammatory capacity in a dose–response manner in subjects with 
dyslipidemia. Redox Biol. 2020, 32, 101474, doi:10.1016/j.redox.2020.101474. 
56. Kao, E.-S.; Tseng, T.-H.; Lee, H.-J.; Chan, K.-C.; Wang, C.-J. Anthocyanin extracted from Hibiscus attenuate 
oxidized LDL-mediated foam cell formation involving regulation of CD36 gene. Chemico-Biol. Interact. 2009, 
179, 212–218, doi:10.1016/j.cbi.2009.01.009. 
57. Qin, Y.; Xia, M.; Ma, J.; Hao, Y.; Liu, J.; Mou, H.; Cao, L.; Ling, W. Anthocyanin supplementation improves 
serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer 
protein in dyslipidemic subjects. Am. J. Clin. Nutr. 2009, 90, 485–492. 
58. Asgary, S.; Sahebkar, A.; Afshani, M.R.; Keshvari, M.; Haghjooyjavanmard, S.; Rafieian-Kopaei, M. Clinical 
Evaluation of Blood Pressure Lowering, Endothelial Function Improving, Hypolipidemic and Anti-
Inflammatory Effects of Pomegranate Juice in Hypertensive Subjects. Phytother. Res. 2014, 28, 193–199, 
doi:10.1002/ptr.4977. 
59. Curtis, P.J.; Kroon, P.A.; Hollands, W.J.; Walls, R.; Jenkins, G.; Kay, C.D.; Cassidy, A.n. Cardiovascular 
Disease Risk Biomarkers and Liver and Kidney Function Are Not Altered in Postmenopausal Women after 
Ingesting an Elderberry Extract Rich in Anthocyanins for 12 Weeks. J. Nutr. 2009, 139, 2266–2271, 
doi:10.3945/jn.109.113126. 
60. Habanova, M.; Saraiva, J.A.; Haban, M.; Schwarzova, M.; Chlebo, P.; Predna, L.; Gažo, J.; Wyka, J. Intake 
of bilberries (Vaccinium myrtillus L.) reduced risk factors for cardiovascular disease by inducing favorable 
changes in lipoprotein profiles. Nutr. Res. 2016, 36, 1415–1422, doi:10.1016/j.nutres.2016.11.010. 
61. Sanabria-Castro, A.; Alvarado-Echeverría, I.; Monge-Bonilla, C. Molecular Pathogenesis of Alzheimer’s 
Disease: An Update. Ann. Neurosci. 2017, 24, 46–54, doi:10.1159/000464422. 
62. D’Cunha, N.M.; Georgousopoulou, E.N.; Boyd, L.; Veysey, M.; Sturm, J.; O’Brien, B.; Lucock, M.; McKune, 
A.J.; Mellor, D.D.; Roach, P.D.; et al. Relationship Between B-Vitamin Biomarkers and Dietary Intake with 
Apolipoprotein E є4 in Alzheimer’s Disease. J. Nutr. Gerontol. Geriatr. 2019, 38, 173–195, 
doi:10.1080/21551197.2019.1590287. 
63. Singh, A.; Kukreti, R.; Saso, L.; Kukreti, S. Oxidative Stress: A Key Modulator in Neurodegenerative 
Diseases. Molecules 2019, 24, 1583, doi:10.3390/molecules24081583. 
64. Eriksen, J.L.; Wszolek, Z.; Petrucelli, L. Molecular Pathogenesis of Parkinson Disease. Arch. Neurol. 2005, 
62, 353–357, doi:10.1001/archneur.62.3.353. 
65. Kang, T.H.; Hur, J.Y.; Kim, H.B.; Ryu, J.H.; Kim, S.Y. Neuroprotective effects of the cyanidin-3-O-β-d-
glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neurosci. Lett. 2006, 391, 122–126. 
66. Joseph, J.A.; Arendash, G.; Gordon, M.; Diamond, D.; Shukitt-Hale, B.; Morgan, D.; Denisova, N. Blueberry 
supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr. 
Neurosci. 2003, 6, 153–162. 
67. Krikorian, R.; Kalt, W.; McDonald, J.E.; Shidler, M.D.; Summer, S.S.; Stein, A.L. Cognitive performance in 
relation to urinary anthocyanins and their flavonoid-based products following blueberry supplementation 
in older adults at risk for dementia. J. Funct. Foods 2020, 64, 103667, doi:10.1016/j.jff.2019.103667. 
Antioxidants 2020, 9, 366 13 of 13 
68. Travica, N.; D’Cunha, N.M.; Naumovski, N.; Kent, K.; Mellor, D.D.; Firth, J.; Georgousopoulou, E.N.; Dean, 
O.M.; Loughman, A.; Jacka, F.; et al. The effect of blueberry interventions on cognitive performance and 
mood: A systematic review of randomized controlled trials. Brain Behav. Immun. 2019, 85, 96–105, 
doi:10.1016/j.bbi.2019.04.001. 
69. Bonafede, R.; Mariotti, R. ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem 
Cells and Extracellular Vesicles. Front. Cell. Neurosci. 2017, 11, 80, doi:10.3389/fncel.2017.00080. 
70. Winter, A.N.; Ross, E.K.; Wilkins, H.M.; Stankiewicz, T.R.; Wallace, T.; Miller, K.; Linseman, D.A. An 
anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the 
hSOD1G93A mouse model of amyotrophic lateral sclerosis. Nutr. Neurosci. 2018, 21, 414–426, 
doi:10.1080/1028415X.2017.1297023. 
71. Soares, J.P.; Cortinhas, A.; Bento, T.; Leitão, J.C.; Collins, A.R.; Gaivã, I.; Mota, M.P. Aging and DNA 
damage in humans: A meta-analysis study. Aging 2014, 6, 432. 
72. Cieslak, K.P.; Baur, O.; Verheij, J.; Bennink, R.J.; van Gulik, T.M. Liver function declines with increased age. 
HPB 2016, 18, 691–696, doi:10.1016/j.hpb.2016.05.011. 
73. Tian, L.; Tan, Y.; Chen, G.; Wang, G.; Sun, J.; Ou, S.; Chen, W.; Bai, W. Metabolism of anthocyanins and 
consequent effects on the gut microbiota. Crit. Rev. Food Sci. Nutr. 2019, 59, 982–991, 
doi:10.1080/10408398.2018.1533517. 
74. Kawabata, K.; Yoshioka, Y.; Terao, J. Role of Intestinal Microbiota in the Bioavailability and Physiological 
Functions of Dietary Polyphenols. Molecules 2019, 24, 370, doi:10.3390/molecules24020370. 
75. Masumoto, S.; Terao, A.; Yamamoto, Y.; Mukai, T.; Miura, T.; Shoji, T. Non-absorbable apple procyanidins 
prevent obesity associated with gut microbial and metabolomic changes. Sci. Rep. 2016, 6, 31208. 
76. Naumovski, N.; Panagiotakos, D.B.; D’Cunha, N.M. Untangling the 2-Way Relationship Between Red Wine 
Polyphenols and Gut Microbiota. Gastroenterology 2020, 158, 48–51, doi:10.1053/j.gastro.2019.10.015. 
77. Vitale, G.; Salvioli, S.; Franceschi, C. Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 
2013, 9, 228–240, doi:10.1038/nrendo.2013.29. 
78. Đudarić, L.; Fužinac-Smojver, A.; Muhvić, D.; Giacometti, J. The role of polyphenols on bone metabolism 
in osteoporosis. Food Res. Int. 2015, 77, 290–298, doi:10.1016/j.foodres.2015.10.017. 
79. Mickle, A.T.; Brenner, D.R.; Beattie, T.; Williamson, T.; Courneya, K.S.; Friedenreich, C.M. The Dietary 
Inflammatory Index® and Alternative Healthy Eating Index 2010 in relation to leucocyte telomere length 
in postmenopausal women: A cross-sectional study. J. Nutr. Sci. 2019, 8, e35, doi:10.1017/jns.2019.32. 
80. Neidle, S.; Parkinson, G.N. The structure of telomeric DNA. Curr. Opin. Struct. Biol. 2003, 13, 275–283, 
doi:10.1016/S0959-440X(03)00072-1. 
81. Ventura Marra, M.; Drazba, M.A.; Holásková, I.; Belden, W.J. Nutrition Risk is Associated with Leukocyte 
Telomere Length in Middle-Aged Men and Women with at Least One Risk Factor for Cardiovascular 
Disease. Nutrients 2019, 11, 508. 
 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
